LINDSAY HOLTZ: Open Payments
NPI 1386965150 · MECHANICSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,651 in 80 payments from 15 companies in 2025. Trend: 2023 $2,193 · 2024 $1,948 · 2025 $1,651
Food & beverage: $1,651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $282 |
| UCB, Inc. | 9 | $237 |
| Novartis Pharmaceuticals Corporation | 11 | $236 |
| Amgen Inc. | 11 | $231 |
| PFIZER INC. | 13 | $141 |
| GlaxoSmithKline, LLC. | 6 | $102 |
| E.R. Squibb & Sons, L.L.C. | 4 | $100 |
| Janssen Biotech, Inc. | 3 | $79 |
| ANI Pharmaceuticals, Inc. | 3 | $78 |
| Genentech USA, Inc. | 2 | $51 |
Products named: Bimzelx, COSENTYX, RINVOQ, ENBREL, XELJANZ, BENLYSTA, ORENCIA, TREMFYA.
Industry payments across VA — which companies pay providers there.
